To see the other types of publications on this topic, follow the link: Cancer prevention center.
Journal articles on the topic 'Cancer prevention center'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Cancer prevention center.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
1
Thom, K. A., M. Kleinberg, and M. C. Roghmann. "Infection Prevention in the Cancer Center." Clinical Infectious Diseases 57, no. 4 (May 7, 2013): 579–85. http://dx.doi.org/10.1093/cid/cit290.
Full text
2
Granwehr, Bruno Palma, Kelly W. Merriman, Zeena Shelal, Hadil Bazerbashi, Patricia A. Brock, Carmen E. Gonzalez, Harrys A. Torres, and Terry Rice. "HIV-testing in a cancer center emergency department." Journal of Clinical Oncology 34, no. 7_suppl (March 1, 2016): 225. http://dx.doi.org/10.1200/jco.2016.34.7_suppl.225.
Full textAbstract:
225 Background: HIV is a cancer-associated virus classically associated with KS, NHL, and cervical cancer, but more recently with anal cancer, lung, and head and neck cancers. HIV testing and treatment are important for cancer patients for three reasons: 1) HIV treatment is associated with reduced transmission of a cancer-associated virus. 2) HIV treatment is associated with improved outcomes of cancer therapy in many cancers. 3) HIV testing optimizes quality of care, since testing is recommended by the Centers for Disease Control and Prevention (CDC) and the US Preventive Services Task Force (USPSTF)(A level recommendation) for patients between the ages of 15 and 65 years of age. Since emergency centers (EC’s) commonly provide immunizations and other preventive care, we implemented HIV testing at our cancer center EC. Methods: In our 44 bed cancer center EC with approximately 25,000 annual visits, routine implementation by physician order was implemented in July 2014. EC information technology (IT) assisted in modification of the order sets and facilitated documentation of specific consent for HIV. Educational materials were disseminated to patients and EC providers. A new consent form with integration of HIV consent, including a check box to refuse HIV testing, was implemented on June 19, 2015. Testing results are described through August 2015. Results: HIV testing increased significantly from July 2014 and August 2015. The impact on institutional testing was considerable, increasing from 1.2% of all HIV testing in 2013 to 15.1% to date in 2015. Between July 2014 and August 2015, 1.4% (0.4% incident) of 852 patients screened positive for HIV. Notably, 83% of patients agreed to HIV testing, but less than 20% of patients were actually tested. The highest refusal rate (18.8%) was in patients over age 70 and lowest (9.9%) in those 21-29 years of age. Conclusions: Routine HIV testing is feasible in a comprehensive cancer center ED, but increased awareness is necessary to optimize testing, given the high acceptance rate. Seroprevalence of HIV is comparable to non-cancer center EC’s (0.5-1.2%). These results demonstrate the acceptance by patients of testing for HIV, with implications in reduction of transmission of this cancer-associated virus.
3
Vogel, Victor. "A clinical cancer prevention curriculum in a comprehensive cancer center." Journal of Cancer Education 6, no. 3 (1991): 133–39. http://dx.doi.org/10.1080/08858199109528109.
Full text
4
Tarallo, Phyllis A. "Developing a Women's Health Cancer Prevention Program in a Liver Transplant Center." Clinical Scholars Review 5, no. 1 (April 2012): 39–42. http://dx.doi.org/10.1891/1939-2095.5.1.39.
Full textAbstract:
Human papillomavirus (HPV) has been detected in 90% of cervical cancers. Cervical cancer is the fourth most common cancer found in women in developed countries and the second most common in underdeveloped countries. People that undergo organ transplant have a high risk of developing other malignancies, depending on the duration and strength of immunosuppressive therapy. This article presents development and implementation of a women's health cancer prevention program in a liver transplant center.
5
Bernstein, Ezra, Ofer Isakov, Lior Galazan, Ari Leshno, Meital Shaked, Eliezer Liberman, Eyal Gur, et al. "Data from an integrated cancer prevention center screening for multiple cancer types." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e13069-e13069. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13069.
Full textAbstract:
e13069 Background: Cancer is the second leading cause of death globally, and was responsible for ~9.6 million deaths in 2018. Importantly, between 30–50% of cancers can be prevented by avoiding risk factors and implementing existing evidence-based prevention strategies. Methods: We present the results of 15758 adults who came to our clinic between 2006 and 2018. Patients were counseled on reducing risk factors and screened for early detection of 11 of the most common cancer types. Patients were examined by specialists in internal medicine, surgery, plastic surgery, OBGYN, urology, oncology, oral surgery, gastroenterology, and others. Women underwent vaginal US, pap smear, mammography (40yr) and US/MRI of the breast with a clinical indication. Men underwent PSA/free PSA ( > 40yr). LDCT for moderate smokers. Colonoscopy was recommended to all subjects ( > 40yr). Results: A total of 7900 (50.1%) men and 7857 women (49.9%) mean age 46.9±11.3 years were screened. A total of 418 (2.7%) malignant lesions were detected in patients who had been screened, 245 (1.6%) of which were detected through our screening: skin 66 (0.4%), prostate 30 (0.2%), thyroid 28 (0.2%), breast 28 (0.2%), colorectal 19 (0.1%), urinary 13 (0.08%), lung 11 (0.07%), cervical 11 (0.07%), other/unknown 9 (0.06%), hematologic 8 (0.05%), ovarian 5 (0.03%), uterine 5 (0.03%), pancreas 3 (0.02%), testicular 3 (0.02%), oropharyngeal 2 (0.01%), hepatobiliary 2 (0.01%), stomach 1 (0.01%), larynx 1 (0.01%). A total of 17 (0.1%) malignant lesions were missed: breast 3 (0.02%), colorectal 3 (0.02%), skin 2 (0.01%), thyroid 2 (0.01%), hematologic 2 (0.01%), pancreas 2 (0.01%), kidney 1 (0.01%), lung 1 (0.01%), brain 1 (0.01%). A total of 147 (0.9%) malignant lesions developed > 1year after a visit. Only forty-nine of the cancer patients (12.5%) died after 18.9±17.8 months at a mean age of 66.5±12.2 years. Significantly, better than the expected cancer mortality in general. First-degree family member with cancer (HR = 1.46) and advanced age (HR = 21.8) was associated with increased cancer risk (P < 0.05). Conclusions: One stop shop cancer screening, in the setting of a multidisciplinary outpatient clinic is feasible, can detect cancer at an early stage, and can significantly improve survival.
6
Lopez, Ana Maria, Jennyffer Morales, Garrett Harding, and Donna Branson. "Utilizing social media for cancer prevention." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e13076-e13076. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13076.
Full textAbstract:
e13076 Background: Cancer prevention and cancer screening behaviors are challenging to support. A myriad of variables including improved knowledge, language access, and health care access serve as facilitators for cancer screening behaviors. Utah is a vast state that is remarkably sparsely populated with more than 96% of the state defined as either rural (< 100 persons per square mile) or frontier (< 7 persons per square mile). Huntsman Cancer Institute is the only academic health center in the Mountain West and serves as the only NCI Comprehensive Cancer Center in the region. Methods: Access to the internet and to social media helps to bridge geography and support engagement. Facebook Live and Twitter Chats were used to deliver content. Language, Spanish, access was considered. Social media was also utilized to connect interested populations with in-person cancer prevention education events. Results: We will present our outreach results by intervention. Conclusions: Our work has successfully engaged rural and Latino populations in cancer prevention activities through social media.
7
Dewald, Lori L. "Cancer Education and Prevention in the Athletic Training Center." Athletic Therapy Today 7, no. 1 (January 2002): 16–19. http://dx.doi.org/10.1123/att.7.1.16.
Full text
8
Schweitzer, Robert J. "A cancer education and prevention center a community program." Cancer 62, S1 (October 15, 1988): 1821–22. http://dx.doi.org/10.1002/1097-0142(19881015)62:1+<1821::aid-cncr2820621323>3.0.co;2-d.
Full text
9
Wolf, Ido, Ari Leshno, Eliezer Liberman, Eyal Gur, Hanoch Elran, Miri Sror, Amira Harlap-Gat, et al. "Ten year experience of an integrated cancer prevention center screening for multiple cancer types." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 1549. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1549.
Full textAbstract:
1549 Background: Cancer is the leading cause of mortality worldwide. Prevention and early detection are pivotal tools for reducing cancer burden. Methods: We describe the 10 year experience (2006-2016) of an integrated cancer prevention center that provides screening for prevention and early detection of 11 most common cancer types. Healthy individuals (20-80 yr) were included. Extensive clinical and epidemiological data was obtained. DNA was extracted from all participants and genotyped for APC I1307K and E1317Q. Patients were examined by specialists in internal medicine, surgery, plastic surgery, OBGYN, urology, oncology, oral surgery, gastroenterology, and others. Women underwent vaginal US and pap smear and (40yr) mammography and US/MRI with a clinical indication. PSA and free PSA for Men ( > 40yr). LDCT for heavy smokers. Colonoscopy was recommended to all subjects ( > 40yr). Results: A total of 6258 (49%) men and 6461 (51%) women mean age 47.0±11.5 year were screened. New malignant lesions were detected in 389 (1.75%) of screeners. The most common cancers were of skin (74, 0.6%), prostate (62, 0.5%), thyroid (51, 0.4%), breast (36, 0.3%), colorectal (22, 0.2%), ovarian (19, 0.1%), uterus (14, 0.1%), testis (12, 0.09%) urinary (9, 0.07%) and lung (10, 0.08%). In 28 patients (0.22%) more than one cancer was detected. Twenty eight of the cancer patients (7.2%) died after 32.4±28.1 months at a mean age of 69.4±14.2 years. Significantly, better than the expected cancer mortality. The APC I1307K and E1317Q variants were detected in 572 (4.8%) and 182 (1.5%) subjects respectively. First degree family member with cancer (OR = 2.02), I1307K carrier ship (OR = 1.53), female gender (OR = 1.23) and advanced age (OR = 1.06) were all associated with statistically significant (P < 0.05) increased cancer risk. Advanced age and first degree family history were also associated with detection of more than one cancer types. Conclusions: One stop shop screening, in the setting of a multidisciplinary outpatient clinic, is feasible and can prevent and detect cancer at an early stage. It significantly improve morbidity and mortality. Impressively the APC I1307K carries an overall increase cancer risk.
10
Meyskens, F. L. "Evolution of Cancer Prevention and Control Program at The Arizona Cancer Center." JNCI Journal of the National Cancer Institute 80, no. 20 (December 21, 1988): 1595–98. http://dx.doi.org/10.1093/jnci/80.20.1595.
Full text
11
Adesta, Regina Ona, and Emanuela Natalia Nua. "PENDIDIKAN KESEHATAN MELALUI MEDIA ONLINE TERHADAP PENGETAHUAN DAN PERILAKU PENCEGAHAN KANKER SERVIKS PADA WUS DI SIKKA." Jurnal Ilmu Keperawatan Maternitas 4, no. 1 (June 17, 2021): 15–26. http://dx.doi.org/10.32584/jikm.v4i1.932.
Full textAbstract:
Background: Reproductive health problems faced by women today are increasing infections in the reproductive organs, which in turn lead to cancer, one of that is cervical cancer. Lack of awareness to prevent cervical cancer is one of the problems that often occur in the health of Fertile Age Women. The effort that needs to be done to prevent cervical cancer is by providing health education through online media, to increase the knowledge and behavior of Fertile Age Women in preventing cervical cancer. The purpose of this research is to determine the effect of health education on early detection of cervical cancer through online media on the knowledge and behavior of Fertile Age Women in cervical cancer prevention in Nanga Public Health Center of Sikka Regency. Method of this research used a pre-experimental design with one group pre-test post-test design method, using a consecutive sampling technique, with as many as 199 respondents. The data collection tool used a questionnaire. Data were analyzed through the Wilcoxon Signed Rank Test with SPSS for windows version 20. Results of this research indicated that there was a very significant effect on the provision of health education through online media on early detection of cervical cancer on knowledge and behavior of cervical cancer prevention of Fertile Age Women in Nanga Public Health Center of Sikka Regency with a p-value of 0.000 (p < 0.05). Providing health education on early detection of cervical cancer with online media can increase knowledge and behavior of cervical cancer prevention of Fertile Age Women. It is hoped that the public health center will provide health education with online media, to support the prevention of covid-19 transmission and to increase the knowledge and behavior of Fertile Age Women in cervical cancer prevention.
12
&NA;. "The Ralph Lauren Center for Cancer Care and Prevention Opens." Oncology Times 25, no. 12 (June 2003): 64. http://dx.doi.org/10.1097/01.cot.0000289844.63984.ea.
Full text
13
Baili, Paolo, Roberta De Angelis, Ilaria Casella, Enrico Grande, Riccardo Inghelmann, Silvia Francisci, Arduino Verdecchia, Riccardo Capocaccia, Elisabetta Meneghini, and Andrea Micheli. "Italian Cancer Burden by Broad Geographical Area." Tumori Journal 93, no. 4 (July 2007): 398–407. http://dx.doi.org/10.1177/030089160709300412.
Full textAbstract:
Aims and background Cancer burden estimates in Italian regions are available for the period 1970-2010 as a result of the project “I TUMORI IN ITALIA” connected with EUROCHIP, the European project on cancer control. The Italian health-care system is organized at a regional level, so regional estimates of cancer indicators are useful to identify priorities for cancer plans. We compared cancer site-specific epidemiological estimates by 3 macro-areas (obtained by grouping regions) to suggest priorities for Italian cancer control plans, both at national and regional levels. Methods Mortality and incidence estimates for all cancers combined and for stomach, colorectal, lung, breast and prostate cancers were downloaded from the website www.tumori.net and aggregated in broad age classes (0-54, 55-74 and 75-84 years) and macro-areas (northern, central and southern Italy). Results Historically, Southern Italy had a lower cancer risk than the Center and North. After 2000 this epidemiological picture disappeared and the incidence and mortality rates in the Center are reaching those of the North. Also the weight of various cancer sites on all cancers has changed in Italy in the last decades. Lung cancer is still the most frequent cancer in the male population in the South, while in the Center-North it has been surpassed by prostate cancer and colorectal cancer. The lung cancer weight on all cancer deaths is increasing in women. Prostate cancer has become the most frequent male cancer in the Center-North in the age class 55-84. Breast cancer is the most frequent cancer in the female population and its incidence rates in the North are higher than those in the Center-South for all age classes. Colorectal cancer incidence rates have dramatically increased in men and colorectal cancer is nowadays the second cancer diagnosed in women in all age classes and macro-areas. Discussion From the epidemiological data here presented we derived the following suggestions and observations for cancer control plans: a) tobacco prevention should focus on the male population in the South, and on female populations in the country as a whole; b) prevention concerning diet and physical activity (risk factors for colorectal cancer) should be considered mainly for men at a national level; c) the coverage of breast cancer screening programs should be increased in the Center-South; d) colorectal cancer screening should be promoted at a national level; e) PSA testing (that is not actually included among the screening programs recommended) for prostate cancer is probably more widespread in the Center-North, resulting in an increased incidence without any evident decline in mortality as yet.
14
Sella, Tal, Ben Boursi, Amira Gat-Charlap, Ilan Aroch, Eliezer Liberman, Menachem Moshkowitz, Ehud Miller, et al. "First report on screening an asymptomatic population for cancer: The yield of an integrated cancer prevention center." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 1564. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1564.
Full textAbstract:
1564 Background: Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality. We aimed to evaluate the utility of cancer screening in an asymptomatic population at an integrated cancer prevention center. Methods: One-thousand consecutive asymptomatic, apparently healthy adults, aged 20-80 years, were screened for early detection of 11 common cancers by routine screening tests. Results: Malignant and benign lesions were found in 2.4% and 7.1% of the screenees, respectively. The most common malignant lesions were in the gastrointestinal tract and breast followed by gynecological and skin. The compliance rate for the different screening procedures was considerably higher than the general Israeli population – 78% compared to 60% for mammography (p<0.001) and 39% compared to 16% for colonoscopy (p<0.001). Advanced age, family history and certain lifestyle parameters were associated with increased risk for cancer. Moreover, polymorphisms in the APC and CD24 genes indicated high cancer risk. When two of the polymorphisms existed in an individual, the risk for a neoplastic lesion was extremely high (OR 2.3 [95% CI 0.94-5.9]). Conclusions: A significant number of neoplastic lesions were diagnosed at an early stage. Polymorphisms in the APC and CD24 genes may identify individuals at an increased risk for cancer. Cancer may be diagnosed at an early stage using the screening facilities of a multidisciplinary outpatient clinic.
15
Lopez, Melissa S., Ellen S. Baker, Cesaltina Lorenzoni, Elvira Xavier Luis, Flora Mabota, Pedro Rafael Machava, Jose Humberto Tavares, Donato Callegaro Filho, Thiago Chulam, and Kathleen M. Schmeler. "Building a Comprehensive Cancer Education Program to Increase Clinical Capacity in Mozambique." Journal of Global Oncology 3, no. 2_suppl (April 2017): 22s—23s. http://dx.doi.org/10.1200/jgo.2017.009589.
Full textAbstract:
Abstract 8 Background: Worldwide, 14.1 million new cancer cases and 8.2 million cancer-related deaths occur annually. Of global cancer deaths, 65% occur in low- and middle-income countries, where there are not enough medical specialists to provide prevention, screening, and treatment services. For example, there are 245 physicians per 100,000 people in the United States and four physicians per 100,000 people in Mozambique. We undertook this work to investigate how to increase clinical capacity and improve cancer prevention and treatment services to ultimately reduce cancer mortality in Mozambique. Methods: Our education program has three complementary components: Strong partnerships with four academic institutions in Brazil, the Ministry of Health of Mozambique, Maputo Central Hospital, and Mavalane Hospital (Maputo) to develop educational programs and collaborative research; use of technology to implement resource-specific and culturally appropriate telementoring programs; and in-country, hands-on training. Collaboration with Brazilian institutions facilitates communication and provides clinical expertise and program expansion opportunities. The telementoring component uses the Project ECHO model, a program that was developed at the University of New Mexico to engage providers in a horizontal manner through regular case-based discussions. Hands-on training complements the telementoring program and increases the level of expertise. Results: Since January 2015, 120 training hours have been provided through ECHO videoconferences to an average of 11 participants on breast, cervical, and head and neck cancers. Two in-country workshops have provided an average of 1,200 training hours to approximately 100 providers in diagnosis, secondary prevention, and surgical management of breast, cervical, and head and neck cancers, as well as training for medical oncology, oncology nursing, palliative care, and radiation physics. Conclusion: Collaborations with Pink Ribbon Red Ribbon, US academic institutions, and industry partners are being developed to strengthen these programs. Funding: The Cancer Prevention Research Institute of Texas Grant No. PP150012; The University of Texas MD Anderson Cancer Center R. Lee Clark Fellowship award, generously supported by the Jeanne F. Shelby Scholarship Fund; The University of Texas MD Anderson Sister Institution Network Fund (SINF) award; The University of Texas MD Anderson Cancer Center HPV-related cancers Moon Shot program; and The University of Texas MD Anderson Cancer Center Cancer Prevention and Control Platform. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST Melissa S. Lopez No relationship to disclose Ellen S. Baker Stock or Other Ownership: Merck Cesaltina Lorenzoni No relationship to disclose Elvira Xavier Luis No relationship to disclose Flora Mabota No relationship to disclose Pedro Rafael Machava No relationship to disclose Jose Humberto Tavares No relationship to disclose Donato Callegaro Filho No relationship to disclose Thiago Chulam Travel, Accommodations, Expenses: AC Camargo Cancer Center Kathleen M. Schmeler Research Funding: Becton Dickinson Patents, Royalties, Other Intellectual Property: UpToDate
16
MacDonald, Deborah J., Kathleen R. Blazer, and Jeffrey N. Weitzel. "Extending Comprehensive Cancer Center Expertise in Clinical Cancer Genetics and Genomics to Diverse Communities: The Power of Partnership." Journal of the National Comprehensive Cancer Network 8, no. 5 (May 2010): 615–24. http://dx.doi.org/10.6004/jnccn.2010.0046.
Full textAbstract:
Rapidly evolving genetic and genomic technologies for genetic cancer risk assessment (GCRA) are revolutionizing the approach to targeted therapy and cancer screening and prevention, heralding the era of personalized medicine. Although many academic medical centers provide GCRA services, most people receive their medical care in the community setting. However, few community clinicians have the knowledge or time needed to adequately select, apply, and interpret genetic/genomic tests. This article describes alternative approaches to the delivery of GCRA services, profiling the City of Hope Cancer Screening & Prevention Program Network (CSPPN) academic and community-based health center partnership as a model for the delivery of the highest-quality evidence-based GCRA services while promoting research participation in the community setting. Growth of the CSPPN was enabled by information technology, with videoconferencing for telemedicine and Web conferencing for remote participation in interdisciplinary genetics tumor boards. Grant support facilitated the establishment of an underserved minority outreach clinic in the regional County hospital. Innovative clinician education, technology, and collaboration are powerful tools to extend GCRA expertise from a National Cancer Institute–designated Comprehensive Cancer Center, enabling diffusion of evidenced-base genetic/genomic information and best practice into the community setting.
17
Zhang, Yawei, Baosen Zhou, Hongmei Zeng, Yongbing Xiang, Jinfeng Wang, Cairong Zhu, Yana Bai, et al. "Novel Approaches for Monitoring and Controlling Major Cancer Risk Factors in China." JCO Global Oncology 6, Supplement_1 (July 2020): 37. http://dx.doi.org/10.1200/go.20.33000.
Full textAbstract:
PURPOSE Globally, approximately one fourth of newly diagnosed cancer cases (24%) and one third of cancer deaths (30%) in 2018 occurred in China. Despite advanced scientific knowledge about risk factors, the incidence of many cancers continuous to increase, which indicates an urgent need for an effective preventive strategy. METHODS For better monitoring and control of major cancer risk factors in China, a research program was launched at the end of 2016. The program aims to develop novel algorithms for cancer risk prediction and prevention, build tools for both real-time risk factor collection and for transmission of intervention-related messages, and to create a cancer prevention platform. It is funded by the Chinese Ministry of Science and Technology. The China National Cancer Center plays a leading role. RESULTS This research program includes 5 projects. The first project will develop a means of collecting data on major cancer risk factors and personalized prevention message-sending apps. The second project will establish 20 population-based, high-quality tumor registries with extensive information on cancer treatment and prognosis. The third project will validate the apps and models developed through the first project in 6 large prospective cohort studies involving diverse populations. The fourth project will apply temporal and spatial high-dimensional data-mining approaches and use historical data, including national cancer incidence and mortality data, air pollution monitoring data, national surveys on smoking and nutrition, etc, to develop a cancer incidence and mortality mapping system. The fifth project will build risk prediction models and establish a cancer prevention Web site to showcase results from other projects. CONCLUSION This study has the potential to revolutionize the path of current cancer prevention by leading it toward personalized cancer prevention.
18
Maihle, Nita J., Douglas A. Levine, Kiran Dhillon, and Deborah Kay Armstrong. "Introduction: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium." International Journal of Gynecologic Cancer 29, Suppl 2 (August 2019): s1. http://dx.doi.org/10.1136/ijgc-2019-000522.
Full textAbstract:
In September 2018, the 12th Biennial Ovarian Cancer Research Symposium was presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research, in Seattle, WA, USA. The 2018 Symposium focused on four broad areas of research: Detection and Prevention of Ovarian Cancer, Genomics and Molecular Mechanisms of Ovarian Cancer, Tumor Microenvironment and Immunology of Ovarian Cancer, and Novel Therapeutics: Response and Resistance of Ovarian Cancer. In addition, a special panel on the 'Role of Advocates in Ovarian Cancer Research’ was featured.
19
Kuznicki, M., A. R. Mallen, S. E. Robertson, S. L. Todd, D. Boulware, S. Martin, E. C. McClung, and S. M. Apte. "Prevention of surgical site infection after hysterectomy at a cancer center." Gynecologic Oncology 149 (June 2018): 157. http://dx.doi.org/10.1016/j.ygyno.2018.04.358.
Full text
20
Sella, Tal, Ben Boursi, Amira Gat-Charlap, Ilan Aroch, Eliezer Liberman, Menachem Moshkowitz, Ehud Miller, et al. "One stop screening for multiple cancers: The experience of an integrated cancer prevention center." European Journal of Internal Medicine 24, no. 3 (April 2013): 245–49. http://dx.doi.org/10.1016/j.ejim.2012.12.012.
Full text
21
Dewi, Adilla Kusuma, Mira Triharini, and Tiyas Kusumaningrum. "The Analysis of Related Factors of Cervical Cancer Prevention Behavior in Reproductive-Aged Women." Pediomaternal Nursing Journal 5, no. 2 (September 4, 2020): 197. http://dx.doi.org/10.20473/pmnj.v5i2.14867.
Full textAbstract:
ABSTRACTIntroduction: Cervical cancer is a disease which can causes and increase infertility, morbidity and mortality of women in the world. The incidence rates of cervical cancer can be reduced by doing primary and secondary preventions. This study aims to determine the relation of self-efficacy, perceived barriers and interpersonal factors to cervical cancer prevention behavior in reproductive-aged women.Method: The study design was correlational study with cross sectional approach. The population were married women of reproductive-age between 15-45 years old in Pacarkeling community health center, Surabaya. The sample of this study was 110 respondents which used cluster sampling technique. The independent variables were perceived barriers, self-efficacy and interpersonal factors and the independent variable was cervical cancer prevention behavior. The data analyzed by using spearman rho statistical test with a significance level of α ≤ 0.05 to find out the related variables to the cervical cancer prevention behavior in reproductive-aged women.Result: The results of this study shows that the perceived barriers (p = 0,000) and interpersonal factors (p = 0,001) were related to cervical cancer prevention behavior (α ≤ 0,05), however self-efficacy was not related to cervical cancer prevention behavior (p = 0,668).Conclusion: Perceived barriers and interpersonal factors could determine the cervical cancer prevention behavior in reproductive-aged women. However, self-efficacy was not proven to determine the cervical cancer prevention behavior. Further, most of women in this study have low self-efficacy, but they have good cervical cancer prevention behavior.Keywords: cervical cancer, interpersonal factors, perceived barriers, self-efficacy, reproductive-aged women
22
Onisim, Andrea, Adina Sabău, Andrada Ciucă, and Adrian Udrea. "Prevention of Chemotherapy-induced Alopecia: Experience of a Cancer Center in Romania." Journal of Medical and Radiation Oncology 1, no. 1 (March 22, 2021): 1–13. http://dx.doi.org/10.53011/jmro.2021.01.01.
Full textAbstract:
"Background: Chemotherapy still represents the backbone of systemic treatment for many solid tumors. Alopecia remains one of its most distressing side effects. Scalp cooling is an effective strategy to reduce the risk of alopecia induced by chemotherapy, therefore this study aimed to assess the efficiency of DigniCap scalp-cooling system in our center. Material&Methods: 113 patients diagnosed with solid tumors, who underwent chemotherapy using the DigniCap scalp-cooling system in our center between January 2018 - December 2020, were included in the study. Alopecia was evaluated by the physician according to Dean’s scale at baseline and after the last cycle of chemotherapy. The primary endpoint was to evaluate scalp-cooling efficiency defined by a Dean's scale score of 0–2 (hair loss ≤50%). Results: 78 (72.3%) out of the 113 patients who used scalp cooling presented hair loss of 50% or less, the majority were females (91.2%) and had a diagnosis of breast cancer (49.6%) or gynecological cancer (27.4%). The mean number of chemotherapy cycles using DigniCap was 4.82 cycles. Hair loss greater than 50% of the scalp surface was observed in 27.7% of patients, the highest grade of alopecia being observed for anthracycline-based chemotherapy. No serious adverse events were reported. Conclusion: The results of this study support the evidence existing so far in the literature. Among patients who underwent chemotherapy for various cancer types, the DigniCap System significantly prevented hair loss and we consider that it should be integrated in the supportive care of patients."
23
Amato, Katharine, Kathryn M. Glaser, Lynda M. Beaupin, Denise A. Rokitka, and Mary E. Reid. "Designing a survivorship and supportive care center at a comprehensive cancer center." Journal of Clinical Oncology 36, no. 7_suppl (March 1, 2018): 159. http://dx.doi.org/10.1200/jco.2018.36.7_suppl.159.
Full textAbstract:
159 Background: Unmet physical, psychosocial, and other support needs of cancer survivors may lead to increased distress, anxiety, and decreased quality of life. Survivorship Clinics may be tailored for specific issues identified through a needs assessment. Methods: An invitation to complete a web-based survey was mailed to 35,420 active patients at a comprehensive cancer center in November 2015. The survey domains included demographics, cancer history, comorbidities, lifestyle, cancer prevention, spiritual and emotional support, symptom management, and interest in specific services. Results: 1,054 surveys were completed. The majority of respondents were female (55.2%; n = 582/1054), had Stage I cancer at diagnosis (43.9%; n = 360/820), and had completed treatment (69.0%; n = 727/1054). Genitourinary (23.0%; n = 238/1034) and breast (20.5%; n = 212/1034) were the most common cancer types among the respondents. Participants identified an average of 4.60 side effects experienced during or after treatment (n = 804); the most common were fatigue (64.5%), pain (37.3%), weight change (33.4%), sleep disturbance (30.2%), and gastrointestinal problems (29.4%). One third of participants reported having a physical side effect that caused anxiety and emotional distress (33.3%; n = 331/995), in particular, sexual function (69.7%; n = 136/195) and cognitive dysfunction (43.6%; n = 85/195). A total of 23.9% of participants had financial concerns due to costs of cancer treatment (n = 238/955). Participants were interested in integrative therapies, most notably yoga (75.1%; n = 289/385), acupuncture (72.4%; n = 155/214), aerobics (62.3%; n = 240/385), Swedish massage (60.5%; n = 225/372), aromatherapy (60.2%; n = 224/372), and homeopathy (55.1%; n = 118/214). Most respondents endorsed wanting information on nutrition (81.5%; n = 380/466). Conclusions: Cancer survivors report vast physical and psychosocial needs during and after cancer treatment, and they have a high interest in nutrition education and integrative therapies. Improved care coordination from a dedicated cancer survivorship and supportive care clinic at a comprehensive cancer center may specifically address survivors’ issues.
24
Pisareva, Lyubov, Nina Lyakhova, Yelena Panferova, Irina Odintsova, Olga Ananina, Tatyana Chimitdorzhieva, Artem Doroshenko, Nadezhda Cherdyntseva, and D. Perinov. "EPIDEMIOLOGICAL ASPECTS OF BREAST CANCER IN THE REPUBLIC OF BURYATIA. WAYS OF PREVENTION." Problems in oncology 64, no. 2 (February 1, 2018): 200–205. http://dx.doi.org/10.37469/0507-3758-2018-64-2-200-205.
Full textAbstract:
Breast cancer is the most common malignancy among women in the Republic of Buryatia estimating 18.4 % of all female cancers. From 1999 to 201З the average standardized incidence rate for breast cancer was 34.2±1.2 per 100,000 in the Republic of Buryatia and 42.3±0.8 in Russia. During a 15-year study period the overall increase in breast cancer incidence rate in the Republic of Buryatia was lower than that in Russia being 20.0 % and 22.9 %, respectively. In 2015 the Government of the Republic of Buryatia and the Ministry of Health approved the Individual Risk Assessment Program developed by the Tomsk National Research Medical Center (No. 2010616823 dated October 13, 2010) to improve cancer care for patients with breast cancer. The program was implemented in 27 medical institutions of the Republic.
25
Presant, Cary A., Ravi Salgia, Prakash Kulkarni, Brian L. Tiep, Shamel Sanani, Benjamin Leach, Kimlin Ashing, et al. "Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites." Journal of Clinical Medicine 9, no. 6 (June 11, 2020): 1820. http://dx.doi.org/10.3390/jcm9061820.
Full textAbstract:
Lung cancer is one of the deadliest and yet largely preventable neoplasms. Smoking cessation and lung cancer screening are effective yet underutilized lung cancer interventions. City of Hope Medical Center, a National Cancer Institute (NCI)- designated comprehensive cancer center, has 27 community cancer centers and has prioritized tobacco control and lung cancer screening throughout its network. Despite challenges, we are implementing and monitoring the City of Hope Tobacco Control Initiative including (1) a Planning and Implementation Committee; (2) integration of IT, e.g., medical records and clinician notification/prompts to facilitate screening, cessation referral, and digital health, e.g., telehealth and social media; (3) clinician training and endorsing national guidelines; (4) providing clinical champions at all sites for site leadership; (5) Coverage and Payment reform and aids to facilitate patient access and reduce cost barriers; (6) increasing tobacco exposure screening for all patients; (7) smoking cessation intervention and evaluation—patient-centered recommendations for smoking cessation for all current and recent quitters along with including QuitLine referral for current smokers and smoking care-givers; and (8) establishing a Tobacco Registry for advancing science and discoveries including team science for basic, translation and clinical studies. These strategies are intended to inform screening, prevention and treatment research and patient-centered care.
26
Abdullah, M. "In the World of Politics and Stigma Around Cancer, Can Cancer Survivors With Political Career Become Cancer Advocates?" Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 180s. http://dx.doi.org/10.1200/jgo.18.72300.
Full textAbstract:
Background and context: According to WHO estimates in 2012, around 20,000 Afghans suffered from various types of cancers while around 15,000 die of this disease. Until late 2015, there was not a single dedicated bed for cancer patients nor there was a doctor, nurse or other cancer care professionals within the structure of Afghan government, especially within the Ministry of Public Health. In November 2014 when Dr. Shinkai Karokhail, member of parliament, returned Afghanistan after spending almost a year overseas for breast cancer treatment misdiagnosed in Afghanistan, she and H.E. the First Lady, Rolla Ghani, began advocating for cancer prevention and control in Afghanistan. They managed to bring the few cancer care professionals and advocates under one umbrella called Afghanistan Cancer Foundation (ACF). Aim: To provide cancer care services to cancer patients. Strategy/Tactics: The main strategy was the involvement of known social and political figures in cancer advocacy. Considering the disparity in cancer incidence among men and women and breast cancer being the leading cancer, one of the most influential people was H.E. the First Lady who is a strong advocate of women rights. The other tactic was the involvement of members of parliament who were cancer survivors. Program/Policy process: Once the political commitment regarding cancer prevention and control was gained, H.E. the First Lady and members of parliament asked the Ministry of Finance to allocate fund for cancer prevention and control. Thus, first fund of only $50,000 was provided by the Ministry of Finance provided to Ministry of Health in the fiscal year 2015. Outcomes: As a result of the advocacy efforts by cancer control advocates, especially by Ms. Shinkai Karokhail, the breast cancer survivor, and H.E. the First Lady of Afghanistan, the first 10-bed day-care and 29-bed IPD cancer center was established in Afghanistan in March 2016. Subsequently, the National Cancer Control Program (NCCP) was created in January 2017 within the Ministry of Public Health. In addition, the first hospital-based cancer registry was formed which will be followed by establishment of Kabul Cancer Registry. The only cancer center provided health care services to around 12,000 patients in 2017 who were either not receiving cancer care services or were traveling to neighboring countries for diagnosis and treatment. What was learned: Cancer patients/survivors who have political career can be the best cancer prevention and control advocates.
27
Samaan, Christen Botros. "Survey of Sun Protection Policies in Juvenile Detention Centers in Pennsylvania: Are we also Protecting Vulnerable Communities?" SKIN The Journal of Cutaneous Medicine 3, no. 2 (March 11, 2019): 82–84. http://dx.doi.org/10.25251/skin.3.2.40.
Full textAbstract:
The incidence rate of skin cancer is increasing in the United States and blistering sunburns during childhood or adolescence is a major risk factor. The Center for Disease Control and Prevention (CDC) developed a set of guidelines to provide schools with a comprehensive approach to preventing skin cancer among adolescents and young people. The objective of this study was to determine the prevalence of sun protection policies, environmental features, and attitudes in institutions responsible for school-aged populations, such as children in juvenile detention centers. Surveys were sent to all (n = 19) public juvenile detention centers in Pennsylvania .Overall, 63.2% (n=12) of the juvenile detention centers in Pennsylvania responded to the survey. Of the 12 centers, 50% (n=6) allow residents to wear hats, 25% (n=3) allow residents to wear sunglasses, 66.7% (n=8) allow residents to wear sunscreen without a provider’s note, and 25% (n=3) provide sun protection education. All the facilities (100%) reported shade-producing structures, but 83.3% (n=10) cover less than 25% of the outdoor activity areas. The CDC’s guidelines include recommendations for schools to encourage skin cancer prevention on school property and elsewhere. Among public juvenile detention centers in PA, we found an absence of policies to reduce sun exposure and a lack of knowledge about the CDC guidelines to prevent skin cancer. Despite these results, administrators are largely in favor of stronger policies and believe sun exposure is an important health issue.
28
Bernstein, Ezra, Shiran Shapira, Shahar Lev-Ari, Ari Leshno, Udi A. Sommer, Lior Galazan, Humaid O. Al-Shamsi, et al. "One-stop-shop for cancer screening: A model for the future." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 10554. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10554.
Full textAbstract:
10554 Background: Cancer is the second leading cause of death globally. Early detection will often greatly reduce mortality for many cancers, increase treatment effectiveness, and improve the quality of life for cancer patients, and, by implementing evidence-based prevention strategies, 30–50% of cancers can be prevented. Screening for different cancer types separately is inefficient. A solution is the Integrated Cancer Prevention Center (ICPC), a program with specialists in each discipline who test for multiple cancers during one visit. Methods: This is a prospective cohort study of 17,104 self-referred, asymptomatic patients who visited the Integrative Cancer Prevention Center (ICPC) between January 1, 2006, and December 31, 2019. Clinical, laboratory, and epidemiological data were recorded by multiple specialists. Patients were given follow-up recommendations and diagnoses when appropriate. The primary measure was the detection and staging of new malignant lesions. Secondary measures included cost-benefit and mortality benefit. Results: We screened 8618 men and 8486 women with an average age of 47.11 ± 11.71 years. Of 259 cancers detected through the ICPC, 49 (18.9%) were stage 0, 115 (44.4%) were stage I, 31 (12%) were stage II, 25 (9.7%) were stage III, and 32 (12.4%) were stage IV. Seventeen cancers were missed, only six of which were within the scope of the ICPC, and 189 cancers developed > one year after the last visit to the ICPC. Compared to the stage of detection for cancers in the US, all cancers except for colon were detected at an earlier stage at the ICPC. Lung was the most significant with 86.7% of cancers detected at stage 0, I, or II at the ICPC compared to only 49.3% caught at those stages in the US. Conclusions: This is a proof of concept for a one-stop-shop approach to asymptomatic cancer screening in a multidisciplinary outpatient clinic. It offers evidence that this screening framework can and should be replicated in other healthcare settings and on a national policy level as it saves lives and money. The encouraging results presented here should further the conversation about the utility of screening and add momentum to the movement for increased screening.[Table: see text]
29
Mitra, Anirban K., and Yang Yang-Hartwich. "Tumor microenvironment and immunology of ovarian cancer: 12th Biennial Rivkin Center Ovarian Cancer Research Symposium." International Journal of Gynecologic Cancer 29, Suppl 2 (August 2019): s12—s15. http://dx.doi.org/10.1136/ijgc-2019-000666.
Full textAbstract:
The 12th Biennial Ovarian Cancer Research Symposium organized by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research held on September 13–15, 2018 covered cutting edge and relevant research topics in ovarian cancer biology and therapy. Sessions included detection and prevention, genomics and molecular mechanisms, tumor microenvironment and immunology, novel therapeutics, and an education session. In this article we provide an overview of the key findings presented in the tumor microenvironment and immunology session.
30
Nurfitriani, Nurfitriani. "GAMBARAN PENGETAHUAN DAN SIKAP WUS DALAM UPAYA PENCEGAHAN KANKER SERVIKS MELALUI TES IVA DI PUSKESMAS PUTRI AYU." Jurnal Akademika Baiturrahim Jambi 8, no. 1 (March 23, 2019): 66. http://dx.doi.org/10.36565/jab.v8i1.104.
Full textAbstract:
In Indonesia Cervical cancer is Cancer with the highest prevalence of about 0.8% or about 98,692 patients.Data from the health department Jambi city indicated that the women of childbearing age that positive cervical cancer on examination IVA at the public health center Putri Ayu Jambi city. This study aimed to determine the correlation of knowledge and attitude of women of childbearing age with cervical cancer prevention efforts. This is a quantitative research by using Cross Sectional design. This study was conducted on Aprils/d August 2018 with samples were 45 respondents, it used questionnaire, analyzed as univariate.The findings indicated that, 24 respondents (53,3%) have hightprevention efforts, 27 respondents (60%) have hight knowledge, and than 21 respondents (46,7%) have positive attitude.The higer the knowledge the better the prevention efforts, the attitude of a person does not affect the influence of prevention efforts, prevention efforts do not affect the attitude. It is expected that the public health center can provide information to childbearing age about prevention cervical cancer by health promotion or counseling and giving motivation to women of childbearing age to do the examination IVA or pap smear.
31
Morgan, Camille, and Makeda Williams. "Building the Global Cancer Workforce: Assessing the Cancer Research and Control Progress of Low- and Middle-Income Country Participants in the National Cancer Institute Summer Curriculum in Cancer Prevention." Journal of Global Oncology 3, no. 2_suppl (April 2017): 29s. http://dx.doi.org/10.1200/jgo.2017.009811.
Full textAbstract:
Abstract 48 Background: The National Cancer Institute (NCI) Summer Curriculum in Cancer Prevention, hosted by NCI’s Cancer Prevention Fellowship Program, has provided interdisciplinary training to physicians, scientists, nurses, and other cancer health care professionals in the principles and practice of cancer prevention, control, and molecular biology and genetics. Since 1998, the summer curriculum has enrolled an increasing number of international participants, with many nominees from All-Ireland NCI Cancer Consortium and the International Atomic Energy Agency’s Programme of Action for Cancer Therapy. NCI’s Center for Global Health selects meritorious international participants, specifically from low- and middle-income countries (LMICs), and has offered limited travel and subsistence scholarships. In spring 2016, the Center for Global Health conducted an evaluation of LMIC participants from 1999 to 2015 to assess the impact of the summer curriculum on participants’ engagement and activities in cancer research and control, including peer-reviewed publications, grants received, scientific presentations, cancer control planning, and advocacy. Methods: We surveyed participants about these topics by using an electronic survey system (Questionnaire Design Studio, v3.0) and analyzed responses in SPSS (SPSS, Chicago, IL) and Excel (Microsoft, Redmond, WA). Results: Of 427 LMIC participants from 1999 to 2015, 357 were surveyed via e-mail invitations to an online survey link, of which 156 responded (44%) during a 4-week study period with follow-up. Overall, 97% report using the knowledge and skills acquired frequently or sometimes, and 80% reported training at least one other person in course content. Nearly 50% reported publishing and 27% reported receiving research funding, of which 84% had not received a grant before participation. Conclusion: Participation of international attendees at the NCI Summer Curriculum builds a global cancer community, utilizing the expertise of Cancer Prevention Fellowship Program in training the cancer health care workforce. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST No COIs from either author.
32
Colditz, Graham A. "Carpe Diem: Time to Seize the Opportunity for Cancer Prevention." American Society of Clinical Oncology Educational Book, no. 34 (May 2014): 8–12. http://dx.doi.org/10.14694/edbook_am.2014.34.8.
Full textAbstract:
INTRODUCTION In his plea for increased resources to implement cancer prevention strategies, Graham Colditz, MD, states that half or more of cancers in the U.S. and other high-income countries are preventable with information already available. He describes the data-driven possibilites: screening, vaccination, exercise, smoking cessation, sun protection, safe sexual practices, and moderate to no alcohol intake, as well as approaches to implement these strategies and makes a compelling case for using resources for this purpose. Dr. Colditz is Associate Director of Prevention and Control in the Alvin J. Siteman Cancer Center, and Niess-Gain Professor in the Department of Surgery at the Washington University School of Medicine. He received his PhD in epidemiology from Harvard University, and his Internal Medicine Training at the Royal Brisbane Hospital in Australia. Dr. Colditz has an enormous volume of publications, with over 800 original research articles. He has worked to identify lifestyle and environmental factors that affect people's health, and to develop and teach cancer prevention strategies at the individual and community levels. His research also powers a website— www.yourdiseaserisk.wustl.edu —that helps people assess their risk of developing cancer, diabetes and other diseases as well as suggesting ways to lead longer, healthier lives. His work is inspirational in combining excellent scientific investigation with dedication to making results available and useful to non-scientists. Gini F. Fleming, MD, Cancer Education Committee Chair
33
Sorensen, Anna, Lisa Norsen, Leway Chen, Elizabeth Palermo, and John Martens. "A Multimodal Skin Cancer Prevention Program for Heart Transplant Patients." Progress in Transplantation 28, no. 3 (June 25, 2018): 263–66. http://dx.doi.org/10.1177/1526924818781561.
Full textAbstract:
Background: Immunosuppressant medications are essential for long-term survival following transplantation but increase the risk of developing skin cancer. Prevention and early detection of skin cancer requires screening and sun protection behaviors that can be achieved with patient education. Problem Statement: Our method for educating post heart transplant patients regarding skin cancer was inconsistent and was not effective. The aim of this project was to develop and integrate a multimodal skin cancer education program to increase knowledge and protective behaviors for heart transplant recipients. Methods: Twenty-five post heart transplant patients who were scheduled to be seen for routine posttransplant care at a single-center transplant center between October 26, 2016, and November 15, 2016, took part in a multimodal skin cancer education program. Results: There was a significant increase in knowledge between pretest and posttest 1 ( P <.01) and pretest and posttest 2 ( P <.01). A significant increase in sun protective behavior was noted. The project noted that knowledge and behavior was retained, knowledge score posttest 1 to posttest 2 ( P = .085), all had seen a dermatologist or had an appointment scheduled, and self skin exam retention was noted between posttest 1 and posttest 2 ( P = .25). Process Addressed: The feasibility of and findings from this intervention have led the clinic team to implement this protocol as part of the standard care for all patients. Conclusions: These data suggests that a multimodal intensive skin cancer education program may be effective at increasing knowledge and protective behavior with heart transplant recipients.
34
Helzlsouer, K. J., D. E. Ford, R. S. A. Hayward, M. Midzenski, and H. Perry. "Perceived Risk of Cancer and Practice of Cancer Prevention Behaviors Among Employees in an Oncology Center." Preventive Medicine 23, no. 3 (May 1994): 302–8. http://dx.doi.org/10.1006/pmed.1994.1042.
Full text
35
Arber, Nadir, Ari Leshno, Shiran Shapira, Eliezer Liberman, Eyal Gur, Hanoch Elran, Sarah Kraus, et al. "One stop screening for multiple cancer types: 10 year experience of an integrated cancer prevention center." Journal of Clinical Oncology 34, no. 15_suppl (May 20, 2016): 1555. http://dx.doi.org/10.1200/jco.2016.34.15_suppl.1555.
Full text
36
Reyes, Clara, Beti Thompson, Katherine J. Briant, and Jason Mendoza. "Understanding a Diverse Cancer Center Catchment Area: A Qualitative Needs Assessment Built on a Theoretical Framework." Cancer Control 27, no. 1 (January 1, 2020): 107327482098302. http://dx.doi.org/10.1177/1073274820983026.
Full textAbstract:
INTRODUCTION: Quantitative approaches to the cancer incidence and mortality of a geographic region may lack understanding of the human context in the region thereby affecting how relevant cancer prevention and control activities can best be targeted to a cancer center’s catchment area. OBJECTIVES: The objective of this study was to obtain and analyze qualitative data that described the barriers and facilitators in a cancer center’s catchment area. A further objective was to use the assessment to plan a comprehensive approach to cancer prevention and control activities in the region. METHODS: Extensive qualitative data were gathered from 32 key informants in the 13 county catchment area. We used the Warnecke Model for Analysis of Population Health and Health Disparities to analyze the qualitative data. We coded factors affecting cancer prevention and control using a directed content analysis approach guided by the Warnecke Model. RESULTS: Four outcome types included fundamental barriers such as political environment and discrimination, gaps in resources, and lack of coordinated activities. Social and physical barriers included distrust, diverse language and cultures, and geographic distance. Individual barriers included lack of system negotiation, health literacy, and poverty. Biological barriers were disparate disease rates in specific groups. CONCLUSION: The analysis and assessment led to the creation of a catchment area wide coalition that used the results to formulate a comprehensive strategic plan to address the barriers in the region.
37
Gharaaghaji, Rasool, Yasamin Pouladi, and Ali Tehranchi. "Study of risk factors for development of urinary bladder cancer in patients in Urmia; a single-center study by logit regression approach." Journal of Renal Injury Prevention 8, no. 4 (October 6, 2019): 306–10. http://dx.doi.org/10.15171/jrip.2019.56.
Full textAbstract:
Introduction: Urinary bladder cancer is the most common genitourinary system malignancy in humans. Objectives: Due to the high prevalence of urinary bladder cancer, having enough knowledge about urinary bladder cancer risk factors can assist in prevention and early recognition of this malignancy. Patients and Methods: In this study case-control, 109 individuals with urinary bladder tumor (as a case group) and 200 individuals without any neoplastic history aged >40 years (as a control group) were included (2016-2017). The data were collected using patients’ files, their pathology reports and also a checklist. The data were analyzed using SPSS version 20, and logistic regression test was applied to investigate the binary outcome. A P value less than 0.05 was considered significant. Results: The results showed, a significant relationship between smoking (P<0.001), having high risk occupation (P<0.001), low water intake (P<0.001) and pickle consumption (P<0.001) with urinary bladder cancer. Conclusion: Smoking is a strong risk factor for urinary bladder cancer. Our study showed smoking and other occupational carcinogens are the main causes of urinary bladder cancers. Thus preventing and controlling these risk factors are important for health schedules.
38
Austin, Allica, Sally Scroggs, Bonnie Nelson, Rachel M. King, and Therese B. Bevers. "Introduction Of Physical Activity Assessment And Follow-up In A Cancer Prevention Center." Medicine & Science in Sports & Exercise 46 (May 2014): 366. http://dx.doi.org/10.1249/01.mss.0000494273.36749.05.
Full text
39
Wickline, M. M. "442: Development of an Outpatient Fall Prevention Program in an Ambulatory Cancer Center." Biology of Blood and Marrow Transplantation 14, no. 2 (February 2008): 157. http://dx.doi.org/10.1016/j.bbmt.2007.12.452.
Full text
40
Lynge, Elsebeth, Linda Kaerlev, Jørn Olsen, Svend Sabroe, Noemia Afonso, Wolfgang Ahrens, Mikael Eriksson, et al. "Rare cancers of unknown etiology: lessons learned from a European multi-center case–control study." European Journal of Epidemiology 35, no. 10 (July 17, 2020): 937–48. http://dx.doi.org/10.1007/s10654-020-00663-y.
Full textAbstract:
Abstract Rare cancers together constitute one fourth of cancers. As some rare cancers are caused by occupational exposures, a systematic search for further associations might contribute to future prevention. We undertook a European, multi-center case–control study of occupational risks for cancers of small intestine, bone sarcoma, uveal melanoma, mycosis fungoides, thymus, male biliary tract and breast. Incident cases aged 35–69 years and sex-and age-matched population/colon cancer controls were interviewed, including a complete list of jobs. Associations between occupational exposure and cancer were assessed with unconditional logistic regression controlled for sex, age, country, and known confounders, and reported as odds ratios (OR) with 95% confidence intervals (CI). Interviewed were 1053 cases, 2062 population, and 1084 colon cancer controls. Male biliary tract cancer was associated with exposure to oils with polychlorinated biphenyls; OR 2.8 (95% CI 1.3–5.9); male breast cancer with exposure to trichloroethylene; OR 1.9 (95% CI 1.1–3.3); bone sarcoma with job as a carpenter/joiner; OR 4.3 (95% CI 1.7–10.5); and uveal melanoma with job as a welder/sheet metal worker; OR 1.95 (95% CI 1.08–3.52); and cook; OR 2.4 (95% CI 1.4–4.3). A confirmatory study of printers enhanced suspicion of 1,2-dichloropropane as a risk for biliary tract cancer. Results contributed to evidence for classification of welding and 1,2-dichloropronane as human carcinogens. However, despite efforts across nine countries, for some cancer sites only about 100 cases were interviewed. The Rare Cancer Study illustrated both the strengths and limitations of explorative studies for identification of etiological leads.
41
Tong, Elisa K., Terri Wolf, David T. Cooke, Nathan Fairman, and Moon S. Chen. "The Emergence of a Sustainable Tobacco Treatment Program across the Cancer Care Continuum: A Systems Approach for Implementation at the University of California Davis Comprehensive Cancer Center." International Journal of Environmental Research and Public Health 17, no. 9 (May 6, 2020): 3241. http://dx.doi.org/10.3390/ijerph17093241.
Full textAbstract:
Tobacco treatment is increasingly recognized as important to cancer care, but few cancer centers have implemented sustainable tobacco treatment programs. The University of California Davis Comprehensive Cancer Center (UCD CCC) was funded to integrate tobacco treatment into cancer care. Lessons learned from the UCD CCC are illustrated across a systems framework with the Cancer Care Continuum and by applying constructs from the Consolidated Framework for Implementation Research. Findings demonstrate different motivational drivers for the cancer center and the broader health system. Implementation readiness across the domains of the Cancer Care Continuum with clinical entities was more mature in the Prevention domain, but Screening, Diagnosis, Treatment, and Survivorship domains demonstrated less implementation readiness despite leadership engagement. Over a two-year implementation process, the UCD CCC focused on enhancing information and knowledge sharing within the treatment domain with the support of the cancer committee infrastructure, while identifying available resources and adapting workflows for various cancer care service lines. The UCD CCC findings, while it may not be generalizable to all cancer centers, demonstrate the application of conceptual frameworks to accelerate implementation for a sustainable tobacco treatment program. Key common elements that may be shared across oncology settings include a state quitline for an adaptable intervention, cancer committees for outer/inner setting infrastructure, tobacco quality metrics for data reporting, and non-physician staff for integrated services.
42
Cira, M., R. Abudu, D. Pyle, S. Akhavan, and K. Duncan. "A Snapshot of Global Oncology Programming at US Cancer Centers: Results of the 2018 US NCI/ASCO NCI-Designated Cancer Center Global Oncology Survey." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 220s. http://dx.doi.org/10.1200/jgo.18.89200.
Full textAbstract:
Background: The US National Cancer Institute (NCI) Center for Global Health (CGH) serves as a clearinghouse of information on global oncology activities within the NCI and across the 70 NCI-designated Cancer Centers. Global oncology, as defined by the American Society of Clinical Oncology (ASCO), “addresses disparities and differences in cancer prevention, care, research, education and the disease's social and human impact around the world”. While CGH routinely reports on NCI-funded global oncology projects conducted at the cancer centers, there is limited reporting of non-NCI funded global oncology activities of the cancer centers. To address this gap, CGH has surveyed the cancer centers about their global oncology programs and projects informally in 2012 and 2014. The 2018 survey, in partnership with ASCO, represents the first systematically conducted survey, with new questions about cancer center global oncology programs, faculty, and trainees. Aim: The aim of the 2018 survey is to develop a summary report of cancer center global oncology programs for use by cancer centers as a knowledge sharing and collaborative tool; by the NCI to inform program development; and, by ASCO to better understand the current state of global oncology training at US institutions. Methods: CGH developed a 2-part online survey with questions about global oncology projects led by cancer centers, and the level of support for global oncology training and faculty engagement at cancer centers. CGH piloted the survey to 7 of the 70 cancer centers (10%) from January to March 2018. Revisions based on the pilot were made, and CGH fielded the survey to the rest of the 63 cancer centers (90%) from March to July 2018. CGH supplemented the survey data with an Internet search of cancer centers' Web sites. The submitted data will be compiled, analyzed, and organized into a summary report for distribution to NCI, ASCO, and the cancer centers. Results: Data from the 7 pilot institutions show that while all 7 institutions (100%) have a global oncology program, there is great variance in the percentage of global oncology faculty who receive external or administrative research grant support for their work. Three institutions (43%) report that 50% or fewer global oncology faculty receive external research grant support, and 6 institutions (86%) report that 50% or fewer global oncology faculty receive cancer center administrative fund support for their work. Additional results and analysis will be available and presented as part of this presentation. Conclusion: In addition to serving as a knowledge sharing and collaboration tool for cancer centers, the global oncology survey allows NCI, ASCO, and global oncology partners to understand the current landscape of and sources of support for global oncology training, research, and programming at the cancer centers. This information will inform future discussions on how to strengthen global oncology programming and partnerships.
43
Ginossar, Tamar. "Disparities and antecedents to cancer prevention information seeking among cancer patients and caregivers attending a Minority-Serving Cancer Center." Journal of Communication in Healthcare 7, no. 2 (July 2014): 93–105. http://dx.doi.org/10.1179/1753807614y.0000000053.
Full text
44
Epstein, Samuel S. "Evaluation of the National Cancer Program and Proposed Reforms." International Journal of Health Services 23, no. 1 (January 1993): 15–44. http://dx.doi.org/10.2190/ul9h-7cfh-ep2h-9rv1.
Full textAbstract:
A statement by 68 prominent national experts in cancer prevention, carcinogenesis, epidemiology, and public health, released at a February 4, 1992, press conference in Washington, D.C., charged that the National Cancer Institute (NCI) has misled and confused the public by repeated claims of winning the war against cancer. In fact, age-standardized incidence rates have escalated to epidemic proportions over recent decades, while the ability to treat and cure most cancers has not materially improved. Furthermore, the NCI has minimized evidence for increasing cancer rates, which are largely attributed to smoking, trivializing the importance of occupational carcinogens as non-smoking attributable causes of lung and other cancers, and to diet per se, in spite of tenuous and inconsistent evidence and ignoring the important role of carcinogenic dietary contaminants. Reflecting this near exclusionary blame-the-victim theory of cancer causation, with lockstep support from the American Cancer Society and industry, the NCI discounts the role of avoidable involuntary exposures to industrial carcinogens in air, water, food, the home, and the workplace. The NCI has also failed to provide any scientific guidance to Congress and regulatory agencies on fundament principles of carcinogenesis and epidemiology, and on the critical needs to reduce avoidable exposures to environmental and occupational carcinogens. Analysis of the $2 billion NCI budget, in spite of fiscal and semantic manipulation, reveals minimal allocations for research on primary cancer prevention, and for occupational cancer, which receives only $19 million annually, 1 percent of NCI's total budget. Problems of professional mindsets in the NCI leadership, fixation on diagnosis, treatment, and basic research, much of questionable relevance, and the neglect of cancer prevention, are exemplified by the composition of the National Cancer Advisory Board. Contrary to the explicit mandate of the National Cancer Act, the Board is devoid of members authoritative in occupational and environmental carcinogenesis. These problems are further compounded by institutionalized conflicts of interest reflected in the composition of past executive President's Cancer Panels, and of the current Board of Overseers of the Sloan-Kettering Memorial Cancer Center, the NCI's prototype comprehensive cancer center, with their closely interlocking financial interests with the cancer drug and other industries. Drastic reforms of NCI policies and priorities are long overdue. Implementation of such reforms is, however, unlikely in the absence of further support from industrial medicine professionals, besides action by Congress and concerned citizen groups.
45
Silkensen, S., N. Wolf, and J. Flanigan. "US NCI's Center for Global Health Regional Centers for Research Excellence Program to Support Research Infrastructure on Noncommunicable Diseases, Metal Health, and Injuries." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 150s. http://dx.doi.org/10.1200/jgo.18.71900.
Full textAbstract:
Background and context: To advance our broad, collective understanding of cancer epidemiology, prevention, diagnosis, and treatment. Sophisticated researchers have an inclination that populations in low- and middle-income countries (LMICs) may hold the essential keys needed to advance our understanding carcinogenesis and other disease progression. Aim: To address this need, the US NCI's Center for Global Health selected 11 meritorious, peer-reviewed teams of investigators, throughout the world, to receive Regional Centers of Research Excellence Planning Grants (RCREs). RCRE centers are designed to focus the US NCI's ongoing, international research investments in cancer epidemiology, prevention, diagnosis, and treatment in places where international populations are essential to making progress for humankind. Strategy/Tactics: The RCRE program galvanizes investigators, clinicians, and patients in LMIC communities. It answers their requests (1) by including investigators from both high-, middle-, and lower-income countries; (2) by encouraging multiple chronic conditions to be studied together; and (3) is driven by the research needs to of the people living in the LMIC communities. Program/Policy process: Furthermore, the RCRE program smooths the way for investigators to plan centers that coordinate the cancer and NCD research needs by providing the investigators with protected time. Lastly, each RCRE team is required to complete a small demonstration project in the LMICs. Outcomes: At the end of the two-year planning grant, all 11 RCRE teams will have created a plan for a Regional Center of Research Excellence. Mechanistically, this plan will have several sections, that together will recount the center's scientific impact on the region. The plan will influence researchers, clinicians, patients, policy makers, and members of civil society as they identify the cancer and other NCD research areas pertinent to their community. Six of the 11 centers focused their cancer pilot research project on breast cancer. Five of the centers focused their pilot projects on cervix, esophageal, oral, prostate, or stomach cancer research. Cancer pilot projects ranged from identifying novel risk factors for liver cancer to investigating the association of single nucleotide polymorphisms variants with metabolic syndrome. All RCREs focused on a second NCD including 6 centers focusing on cardiovascular disease and 5 centers focusing on diabetes, injury, or depression research. What was learned: With a modest financial investment, 11 2-year planning grants can be supported. These 11 grants provide finance support for multiple principal investigators, at 23 distinct institutions. These 11 RCRE centers span 16 countries and 10 NCDs. Remarkably, during the first half of their 36-month project period, they have collectively published 10 manuscripts. The NCI Center for Global Health encourages the UICC/WCC community to become involved in this exciting research program.
46
Juhasz, Margit, Jamie Fortman, Jessica Lin, Yessica Landaverde, Joshua Levy, Christine Pham, Nicole Myers, et al. "The Perception of Chemotherapy-Induced Alopecia in Cancer Patients Currently Undergoing Treatment." SKIN The Journal of Cutaneous Medicine 4, no. 1 (January 28, 2020): 34–56. http://dx.doi.org/10.25251/skin.4.1.6.
Full textAbstract:
Background: Chemotherapy-induced alopecia (CIA) is a common adverse effect of chemotherapy. 8% of patients consider declining chemotherapy due to CIA risk.Objective: To determin whether cancer patients who are actively receiving chemotherapy are interested in preventing or treating CJA.Materials and Methods: This is a survey-based, cross-sectional study of cancer patients undergoing chemotherapy infusion at a tertiary medical center. Data including demographics, cancer diagnosis, medical literacy, quality of life, hair quality satisfaction, and costs patients were willing to accrue for CIA prevention/treatment were gathered.Results: Sixty-two adults were enrolled, mostly 55 to 64 years of age, female (72.6%), and White (63.8%). Many patients were diagnosed with malignancies associated with a high rate of morbidity-mortality including ovarian, lung and pancreatic. In our cohort, all patients would not decline cancer treatment based on CIA risk. 94.6% of patients were unwilling to risk cancer recurrence, 80.9% additional side effects, 55.8% extra time outside of infusion and 47.9% to pay out-of-pocket for CIA prevention/treatment.Conclusions: Patients with high cancer disease burden will not decline current treatment due to CIA risk. In addition, they are not willing to sustain additional discomfort, cost or time to prevent or treat CIA.
47
Jou, Katerina, Madeline R. Sterling, Rosio Ramos, Francesse Antoine, David M. Nanus, and Erica Phillips. "Eliciting the Social Determinants of Cancer Prevention and Control in the Catchment of an Urban Cancer Center." Ethnicity & Disease 31, no. 1 (January 21, 2021): 23–30. http://dx.doi.org/10.18865/ed.31.1.23.
Full textAbstract:
Objective: The objectives of this study were two-fold: 1) to engage community stakeholders in identifying the top three social determinant of health (SDOH) barriers to the early detection and treatment of cancer in their respective communities; and 2) to develop a tailored plan responsive to the potential social risks identified within the catchment of an urban academic cancer center.Methods: Stakeholders from four neighborhoods in Brooklyn, New York with disproportionate cancer burden were recruited; the nominal group technique, a semi-quantitative research method, was used to elicit the SDOH barriers. Responses were consolidated into categories and ranked by points received.Results: 112 stakeholders participated in four community-based meetings. The SDOH categories of economic stability, education, and community and social context were identified as the top barriers. The themes of lost wages/employment, competing priorities, and the inability to afford care embodied the responses about economic stability. The domain of education was best described by the themes of low health literacy, targeted health topics to fill gaps in knowledge, and recommendations on the best modalities for improving health knowledge. Lastly, within the category of community and social context, the themes of stigma, bias, and discrimination, eroding support systems, and cultural misconceptions were described.Conclusion: The implications of our study are three-fold. First, they highlight the strengths of the nominal group technique as a methodology for engaging community stakeholders. Second, our analysis led to identifying a smaller set of social priorities for which tailored screening and practical solutions could be implemented within our health care system. Third, the results provide insight into the actual types of interventions and resources that communities expect from the health care sector.Ethn Dis. 2021;31(1):23-30; doi:10.18865/ ed.31.1.23
48
Zhu, Jun, Huiping Li, Zhengfu Fan, Yunong Gao, Meifeng Tu, Bin Shao, and Tian Gao. "Efficacy and safety of PEG-rhG-CSF in primary and secondary prevention of chemotherapy-induced neutropenia." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e19051-e19051. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e19051.
Full textAbstract:
e19051 Background: This study was to evaluate the efficacy and safety of PEG-rhG-CSF (brand name:jinyouli) in primary and secondary prevention of CIN(chemotherapy-induced neutropenia). Methods: This is a single-center,one-arm clinical study.Patients with non-myeloid malignant tumors were enrolled. PEG-rhG-CSF was given subcutaneously at 24-48h after chemotherapy. The indicator was febrile neutropenia(FN) and IV grade absolute neutrophil count. Results: From January 2016 until June 2018,217 patients were enrolled including 119 lymphoma patients, 50 breast cancer patients, 30 bone tumor patients,18 gynecologic oncology patients, and While146 with primary prevention and 71 with secondary prevention. The incidence of FN was 5.0% (35/692), which was 4.3% (21/478) in the primary prevention patients and 6.5% (14/214) in the secondary prevention patients ( p= 0.233).Logistic regression analysis showed that the longer the treatment cycle, the lower the incidence of FN. Comparison of the indicators of different chemotherapy cycles showed that the IV grade absolute neutrophil count (ANC) reduction was significantly lower in the primary prevention patients than in the secondary prevention patients in the first cycle of chemotherapy[17.1%(25/146) vs.46.5%(33/70),p = 0.000],the incidence of FN and IV grade ANC reduction were significantly lower in the second cycle of treatment than in the first cycle(p < 0.05).The adverse event were mainly bone pain, the incidence of 1/2 grade bone pain was 3.7% (8/217) and the incidence of grade 3/4 bone pain was 1.8% (4/217). Conclusions: The prevention of CIN with PEG-rhG-CSF after chemotherapy can effectively reduce the incidence of FN.For the first chemotherapy cycle, primary prevention is more effective than secondary prevention in preventing the incidence of IV grade ANC reduction. Clinical trial information: NCT02905916.
49
Surabhi Gupta, Bhupendra Singh Chahar, and Kumari Puja. "Changing pattern of female cancer during last 10 years-experience from a Tertiary Cancer Center." International Journal of Science and Research Archive 2, no. 2 (May 30, 2021): 018–27. http://dx.doi.org/10.30574/ijsra.2021.2.2.0051.
Full textAbstract:
Background-The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer causing behaviors, particularly smoking in economically developing countries and life style changes. India exhibits heterogeneity in cancer. Since two decade changes in the pattern of cancer has been observed in various studies. So this retrospective study was done to observe the changing pattern in female cancer in our institution during last 10 years. Aims and object-To observe the changes in female malignancies during last 10 years in terms of age shifting and site of presentation. Result/observation-Ca cervix is on decreasing trend while ca breast is on increasing pattern.Ca gallbladder, ca esophagus, colorectal cancer and ca ovary are on gradually increasing trend while hematological malignancy is showing a sharp rise in trend. Conclusion- Evidence-based policy decision on steps for cancer prevention and cancer control should be formulated. More emphasis should be given on the cancer which are showing an increasing trend so that proper and effective screening and cancer control program can be implicated.
50
Grimm, Brandon, Nada Alnaji, Shinobu Watanabe-Galloway, and Melissa Leypoldt. "Cervical Cancer Attitudes and Knowledge in Somali Refugees in Nebraska." Pedagogy in Health Promotion 3, no. 1_suppl (May 11, 2017): 81S—87S. http://dx.doi.org/10.1177/2373379917698673.
Full textAbstract:
The state of Nebraska has a growing number of refugees with diverse backgrounds and health needs. To address these needs, a collaborative project was developed by the local performance site of the Midwestern Public Health Training Center at the University of Nebraska Medical Center, College of Public Health, and the Nebraska Department of Health and Human Services, Division of Public Health, Office of Women’s and Men’s Health. The purpose of this 2-year project is to improve the quality of services offered by the Office of Women’s and Men’s Health by assessing risk, knowledge, and preventive screening practices in refugee populations and provide recommendations to increase cancer-screening rates. The focus of the project was on cervical cancer prevention of Somali women refugees in Nebraska. In Year 1 of the project (2015-2016), a Refugee Screening Collaborative was created to provide input and recommendations throughout the project; focus groups and a literature review were completed to explore the knowledge, attitudes, and beliefs of cervical cancer screening and human papillomavirus vaccine among refugees and health care providers; and recommendations were made for the development and implementation of curricula and interventions that address the unique cultural and literacy needs of the population. This project demonstrates the importance of the Public Health Training Center program for building mutually beneficial partnerships between academia and practice.